As the crypto market shifts toward more utility-driven assets, Mutuum Finance (MUTM) is beginning to stand out as a project with both momentum and substance. The protocol has quietly attracted a ...

Q4 2024 Management View CEO George Lasezkay highlighted the company's progress in advancing its suprachoroidal delivery platform, noting over 15,000 suprachoroidal injections performed to date. He ...

BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...

Dermata Therapeutics, Inc. (Nasdaq: DRMA, DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical skin diseases and aesthetic applications, today ...

CG Oncology (CGON) announced that 83 out of 110 patients achieved a complete response at any time in a Phase 3 study of cretostimogene ...

Cassava Sciences (SAVA) shared topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate AD. Topline data indicate ...

The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.

The phase 3 COAST trial investigating 2 mg sozinibercept for the treatment of wet age-related macular degeneration in ...

The Tennessee Department of Transportation (TDOT) said they’re moving into a new phase of a years-long project that will help to ease congestion.

A new drug application for povorcitinib is expected to be filed in late 2025 to early 2026 to treat adult patients with ...

A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to ...

The second phase of Nintendo's game launch plan is then reportedly set for around October-November, and will have a greater ...